22 February 2021>: Clinical Research
Morbidity and All-Cause Mortality Following Radical Prostatectomy Compared with Observation for Localized Prostate Cancer in Chinese Men: A Non-Randomized Retrospective StudyXi Zhang 1ABF* , Xiang Li 1ABF* , Qiwei Yu 1BDF , Jun Ma 1CDF , Xuemin Zeng 1BCF , Li Xue 2DEF*
Med Sci Monit 2021; 27:e928596
Table 3 Risk factor for all-cause mortality.
|Men died in the follow-up||291|
|Characteristics at the time of diagnosing||Odd ratio||95% confidence limit||p-Value|
|Age (≥65-year vs*||2.451||0.451–0.982||0.041|
|Prostate specific antigen level (>10 ng/mL vs ≤10 ng/mL)||1.052||0.681–0.941||0.053|
|Charlson score (≥1 vs 0)||0.893||0.611–0.872||0.098|
|Gleason score (≥7 vs*||1.151||0.511–0.852||0.049|
|Tumor stage (≥2c vs tumor stage ≤2b)*||1.892||0.482–0.912||0.045|
|CAPRA scores (high vs low and intermediate)||1.031||0.512–0.895||0.058|
|Multivariate analysis. Data of survived men (n=119) were considered the reference standard. Odd ratio >1 and -value|
* Significant risk factor associated with all-cause mortality.
CAPRA scores – Cancer of Prostate Risk Assessment scores.